GMAB
Price
$20.30
Change
-$0.14 (-0.68%)
Updated
Jul 3 closing price
Capitalization
12.61B
32 days until earnings call
IMCR
Price
$33.02
Change
+$0.27 (+0.82%)
Updated
Jul 3 closing price
Capitalization
1.66B
31 days until earnings call
Interact to see
Advertisement

GMAB vs IMCR

Header iconGMAB vs IMCR Comparison
Open Charts GMAB vs IMCRBanner chart's image
Genmab A/S ADS
Price$20.30
Change-$0.14 (-0.68%)
Volume$1.13M
Capitalization12.61B
Immunocore Holdings
Price$33.02
Change+$0.27 (+0.82%)
Volume$121.19K
Capitalization1.66B
GMAB vs IMCR Comparison Chart in %
Loading...
GMAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IMCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GMAB vs. IMCR commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GMAB is a Hold and IMCR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 07, 2025
Stock price -- (GMAB: $20.30 vs. IMCR: $33.02)
Brand notoriety: GMAB and IMCR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GMAB: 75% vs. IMCR: 28%
Market capitalization -- GMAB: $12.6B vs. IMCR: $1.66B
GMAB [@Biotechnology] is valued at $12.6B. IMCR’s [@Biotechnology] market capitalization is $1.66B. The market cap for tickers in the [@Biotechnology] industry ranges from $316.35B to $0. The average market capitalization across the [@Biotechnology] industry is $2.38B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GMAB’s FA Score shows that 0 FA rating(s) are green whileIMCR’s FA Score has 0 green FA rating(s).

  • GMAB’s FA Score: 0 green, 5 red.
  • IMCR’s FA Score: 0 green, 5 red.
According to our system of comparison, GMAB is a better buy in the long-term than IMCR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GMAB’s TA Score shows that 3 TA indicator(s) are bullish while IMCR’s TA Score has 5 bullish TA indicator(s).

  • GMAB’s TA Score: 3 bullish, 7 bearish.
  • IMCR’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, IMCR is a better buy in the short-term than GMAB.

Price Growth

GMAB (@Biotechnology) experienced а -2.07% price change this week, while IMCR (@Biotechnology) price change was +3.12% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.30%. For the same industry, the average monthly price growth was +17.40%, and the average quarterly price growth was -0.11%.

Reported Earning Dates

GMAB is expected to report earnings on Aug 07, 2025.

IMCR is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+6.30% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GMAB($12.6B) has a higher market cap than IMCR($1.66B). IMCR YTD gains are higher at: 11.932 vs. GMAB (-2.731). GMAB has higher annual earnings (EBITDA): 1.35B vs. IMCR (-97K). GMAB has more cash in the bank: 3.23B vs. IMCR (837M). GMAB has less debt than IMCR: GMAB (143M) vs IMCR (434M). GMAB has higher revenues than IMCR: GMAB (3.12B) vs IMCR (334M).
GMABIMCRGMAB / IMCR
Capitalization12.6B1.66B759%
EBITDA1.35B-97K-1,393,814%
Gain YTD-2.73111.932-23%
P/E Ratio11.91N/A-
Revenue3.12B334M933%
Total Cash3.23B837M385%
Total Debt143M434M33%
FUNDAMENTALS RATINGS
GMAB: Fundamental Ratings
GMAB
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
58
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
42
PRICE GROWTH RATING
1..100
61
P/E GROWTH RATING
1..100
93
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GMABIMCR
RSI
ODDS (%)
Bearish Trend 4 days ago
69%
Bearish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
60%
Bullish Trend 4 days ago
71%
Momentum
ODDS (%)
Bearish Trend 4 days ago
68%
Bullish Trend 4 days ago
82%
MACD
ODDS (%)
Bearish Trend 4 days ago
68%
Bearish Trend 4 days ago
82%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
68%
Bullish Trend 4 days ago
75%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
71%
Bearish Trend 4 days ago
84%
Advances
ODDS (%)
Bullish Trend 27 days ago
62%
N/A
Declines
ODDS (%)
Bearish Trend 4 days ago
68%
Bearish Trend 17 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
80%
Bearish Trend 7 days ago
90%
Aroon
ODDS (%)
Bullish Trend 4 days ago
57%
Bullish Trend 4 days ago
70%
View a ticker or compare two or three
Interact to see
Advertisement
GMAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IMCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
LIVR27.160.26
+0.97%
Intelligent Livermore ETF
TSPA39.370.31
+0.79%
T. Rowe Price US Equity Research ETF
INOV32.250.04
+0.11%
Innovator Intl Dev Pwr Bffr ETF - Nov
TAIL11.88-0.06
-0.46%
Cambria Tail Risk ETF
NAIL58.36-3.10
-5.04%
Direxion Daily Hmbldrs&Supls Bull 3X ETF

GMAB and

Correlation & Price change

A.I.dvisor indicates that over the last year, GMAB has been loosely correlated with ARGX. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if GMAB jumps, then ARGX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GMAB
1D Price
Change %
GMAB100%
-0.68%
ARGX - GMAB
40%
Loosely correlated
-0.30%
ARVN - GMAB
38%
Loosely correlated
+0.63%
TECH - GMAB
37%
Loosely correlated
-0.08%
BMRN - GMAB
37%
Loosely correlated
N/A
IMCR - GMAB
37%
Loosely correlated
+0.82%
More

IMCR and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMCR has been loosely correlated with IDYA. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if IMCR jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMCR
1D Price
Change %
IMCR100%
+0.82%
IDYA - IMCR
51%
Loosely correlated
+0.82%
NRIX - IMCR
50%
Loosely correlated
+2.33%
XENE - IMCR
47%
Loosely correlated
-0.33%
KYMR - IMCR
46%
Loosely correlated
+0.58%
BDTX - IMCR
46%
Loosely correlated
-0.77%
More